Jiangsu Hengrui Medicine
600276.SS
7,70 €
Share price
2.84%
Change (1 day)
49.16%
Change (1 year)
Categories
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics
EPS for Jiangsu Hengrui Medicine (600276.SS)
EPS in 2025 (TTM): 0,12 €
According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is 0,11 €. In 2024 the company made an earnings per share (EPS) of 0,12 € an increase over its 2023 EPS that were of 0,08327 €.
EPS history for Jiangsu Hengrui Medicine from 2000 to 2025
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2025 (TTM) | 0,12 € | -0.77% |
| 2024 | 0,12 € | 42.43% |
| 2023 | 0,08327 € | 8.77% |
| 2022 | 0,07656 € | -20.62% |
| 2021 | 0,09645 € | -26.59% |
| 2020 | 0,13 € | 27.24% |
| 2019 | 0,10 € | 28.41% |
| 2018 | 0,08041 € | 20.04% |
| 2017 | 0,06699 € | 31.21% |
| 2016 | 0,05105 € | 11.46% |
| 2015 | 0,04580 € | 36.27% |
| 2014 | 0,03361 € | 19.77% |
| 2013 | 0,02806 € | 18.05% |
| 2012 | 0,02377 € | 23.9% |
| 2011 | 0,01919 € | 26.9% |
| 2010 | 0,01512 € | 12.37% |
| 2009 | 0,01346 € | 56.6% |
| 2008 | 0,008592 € | 9.18% |
| 2007 | 0,007870 € | 114.48% |
| 2006 | 0,003670 € | 64.83% |
| 2005 | 0,002226 € | 35.55% |
| 2004 | 0,001642 € | 29.73% |
| 2003 | 0,001266 € | 19.86% |
| 2002 | 0,001056 € | -2.71% |
| 2001 | 0,001086 € | 1.02% |
| 2000 | 0,001075 € |